Genomics is more than family history.
Genetic Technologies is a World Leader in Genetic Risk Assessment. Our brand geneType offers integrated risk testing for a range of serious conditions.
By knowing your risk, you and your healthcare professional can put together a personalised preventive health plan, and may help save your life.
Comprehensive Risk Prediction
Find our what your DNA say about you, your family and your lifestyle. Designed for those who may have a family history of cancer, cardiovascular and metabolic disease and want to know their individual risk.
Risk Stratification Panel for Men
Risk Stratification Panel for Women
Develop your own personalized preventative pathway with a healthcare professional. Designed for those who know their family history and want to further understand their disease risk.
GeneType Multi-Risk Test for Men
GeneType Multi-Risk Test for Women
A leader in personalised predictive genetics
GeneType Integrated Risk, Polygenic Risk (PRS) and Clinical Risk (CRS)
Inherited Monogenic Disease (Germline)
Non-invasive Prenatal Testing
DNA Testing (Ancestry, Paternity)
PetgenTM Animal Test
and geneType delivers.
Our expert scientific team has dedicated the last 20 years to translating research into validated clinical tests with actionable outcomes for patients.
Our extensive range of patents, peer-reviewed publications and validated tests reflects this commitment to making personalised, predictive healthcare a reality.
GeneType gives you the tools you need to provide personalised, preventative healthcare.
Genetype tests integrates clinical, familial and genetic risk factors to provide a more comprehensive risk profile.
For example, geneType for Breast Cancer supports identification of four times as many women who are at high risk for breast cancer compared with traditional prediction models.²
This information will then allow you and your healthcare professional to develop personalised, preventive health plans based on screening and risk factor management.
- Dite GS et al. Cancer Epidemiol Biomarkers Prev 2016;25:359–65.
- Genetic Technologies Ltd. Internal Unpublished Data.
Keep up-to-date with our latest advances
Sign up to our newsletter to stay informed about our latest advances and how these could support you.